---
title: Carbogen Amcis vs WuXi XDC
slug_a: carbogen-amcis
slug_b: wuxi-xdc
site: cdmo
review_signal_gate: closed
canonical_path: /compare/carbogen-amcis/wuxi-xdc
---

# Carbogen Amcis vs WuXi XDC

Side-by-side profile data from each company listing on this directory.

## Carbogen Amcis

- Profile: [/companies/carbogen-amcis](/companies/carbogen-amcis)

Carbogen Amcis — Full-service CDMO offering integrated drug substance and sterile drug product development and manufacturing from early phase through commercialization, with specialized capabilities in API synthesis, process development, analytical services, and stability testing across multiple scales.

Services: 18. Modalities: 2. Indications: 0. Locations: 14. Certifications: 5. The strongest documented coverage currently appears in services (18).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Flow Chemistry & Continuous Manufacturing
- Solid-State Chemistry & Polymorph Screening
- ADC (Antibody-Drug Conjugate) Manufacturing
- ADC Payload & Linker Synthesis
- Bioconjugation Services
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Lyophilization (Freeze Drying)
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Antibody-Drug Conjugate (ADC)

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing
- Solid-state characterization

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Lyophilized Vials
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- Flow Chemistry
- Hydrogenation
- Cryogenic (−80 °C)

## WuXi XDC

- Profile: [/companies/wuxi-xdc](/companies/wuxi-xdc)

WuXi XDC — WuXi XDC is a leading CRDMO offering integrated discovery, development, and cGMP manufacturing services for antibody drug conjugates (ADCs) and bioconjugates, with proximately located facilities that reduce development timelines and costs.

Services: 12. Modalities: 2. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (12).

### Services

- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- ADC Payload & Linker Synthesis
- Bioconjugation Services
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Lyophilization (Freeze Drying)
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development

### Modalities

- Biologics (Monoclonal Antibodies)
- Antibody-Drug Conjugate (ADC)

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Lyophilized Vials
- Expression: Mammalian